Page last updated at 17:10 GMT, Thursday, 28 January 2010

AstraZeneca set to cut 8,000 jobs

Generic pills
AstraZeneca is one of the world's largest pharmaceutical firms

Pharmaceutical giant AstraZeneca is to cut a further 8,000 jobs across its worldwide operations.

The workforce reduction is in addition to the 12,600 global positions that have already been trimmed under the firm's continuing cost-cutting plans.

The UK group said the latest round of job cuts would be implemented over the next four years.

An AstraZeneca spokeswoman said the company had yet to reveal how many UK positions would be affected.

The latest global cuts are to take place across the firm's sales and marketing, business infrastructure, research and development (R&D), and supply chain operations.

The company also said that some R&D sites may close.

AstraZeneca is seeking to achieve cost savings of about £1.1bn ($1.8bn) by 2014.

The job cuts announcement came as AstraZeneca reported an annual pre-tax profit of £6.7bn for 2009, up 24% from 2008. Annual revenues were up 7% to £20.2bn.

Shares in AstraZeneca fell 4.6% to £29.05.



Print Sponsor


SEE ALSO
Firm 'suppressed' drug test data
26 Jan 10 |  Health
AstraZeneca profits increase 40%
30 Apr 09 |  Business

RELATED INTERNET LINKS
The BBC is not responsible for the content of external internet sites


FEATURES, VIEWS, ANALYSIS
Has China's housing bubble burst?
How the world's oldest clove tree defied an empire
Why Royal Ballet principal Sergei Polunin quit

BBC navigation

BBC © 2014 The BBC is not responsible for the content of external sites. Read more.

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.

Americas Africa Europe Middle East South Asia Asia Pacific